Rybelsus is a GLP-1 receptor agonist that slows gastric emptying, which can increase stomach pressure and contribute to reflux symptoms Gastro-oesophageal reflux and dyspepsia are listed as potential adverse effects in MHRA and EMA prescribing information Lifestyle modifications including smaller meals, avoiding trigger foods, and remaining upright after eating may help manage symptoms Over-the-counter antacids or alginates can provide symptomatic relief when taken at least 30 minutes after Rybelsus Contact your GP if reflux symptoms persist beyond one to two weeks despite management strategies or if you develop difficulty swallowing Seek immediate medical attention for severe persistent abdominal pain, acute chest pain, or signs of allergic reaction Table of Contents What Is Rybelsus and How Does It Work
Some patients anecdotally report differences in side effects based on time of day of injection, though this isn't established in clinical evidence
Abstract Selenium (Se) has a multilevel, complex and dynamic effect on the human body as a major component of selenocysteine, incorporated into selenoproteins, which include the selenocysteine-containing enzymes iodothyronine deiodinases
however, it also has negative side effects that could potentially cause harm to patients
Clinical Trial Results Related to Diarrhea In clinical trials, patients using tirzepatide were carefully monitored for side effects